A COMPARATIVE-EVALUATION OF MOXALACTAM - ANTIMICROBIAL ACTIVITY, PHARMACOKINETICS, ADVERSE REACTIONS, AND CLINICAL EFFICACY

被引：0

作者：

FITZPATRICK, BJ

STANDIFORD, HC

机构：

[1] VET ADM MED CTR,DEPT MED,DIV INFECT DIS,BALTIMORE,MD 21218

[2] UNIV MARYLAND,SCH MED,BALTIMORE,MD 21201

来源：

PHARMACOTHERAPY | 1982年 / 2卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：197 / 212

页数：16

共 106 条

[1] ABBRUZZESE J, 1981, 21ST INT C ANT AG CH
[2] MOXALACTAM PHARMACOKINETICS DURING HEMODIALYSIS
ARONOFF, GR
SLOAN, RS
MONG, SA
LUFT, FC
KLEIT, SA
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1981, 19 (04) : 575 - 577
[3] INVITRO ANTI-MICROBIAL ACTIVITY OF CEFOPERAZONE, CEFOTAXIME, MOXALACTAM (LY127935), AZLOCILLIN, MEZLOCILLIN, AND OTHER BETA-LACTAM ANTIBIOTICS AGAINST NEISSERIA-GONORRHOEAE AND HEMOPHILUS-INFLUENZAE, INCLUDING BETA-LACTAMASE-PRODUCING STRAINS
BAKER, CN
THORNSBERRY, C
JONES, RN
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1980, 17 (04) : 757 - 761
[4] TENTATIVE INTERPRETIVE STANDARDS FOR DISK SUSCEPTIBILITY TESTS WITH MOXALACTAM (LY127935)
BARRY, AL
THORNSBERRY, C
JONES, RN
GERLACH, EH
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1980, 18 (05) : 716 - 721
[5] BARTLETT JG, 1981, REV INFECT DIS, V3, P535
[6] INVITRO ACTIVITY OF LY127935
BARZA, M
TALLY, FP
JACOBUS, NV
GORBACH, SL
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1979, 16 (03) : 287 - 292
[7] BELOHRADSKY BH, 1980, LANCET, V1, P61
[8] PHARMACOKINETICS OF MOXALACTAM IN SUBJECTS WITH VARIOUS DEGREES OF RENAL DYSFUNCTION
BOLTON, WK
SCHELD, WM
SPYKER, DA
OVERBY, TL
SANDE, MA
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1980, 18 (06) : 933 - 938
[9] COMPARATIVE INVITRO ACTIVITY OF 1-OXA-BETA-LACTAM (LY127935) AND CEFOPERAZONE WITH OTHER BETA-LACTAM ANTIBIOTICS AGAINST ANAEROBIC-BACTERIA
BOROBIO, MV
AZNAR, J
JIMENEZ, R
GARCIA, F
PEREA, EJ
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1980, 17 (02) : 129 - 131
[10] BROWN AE, 1981, 21ST INT C ANT AG CH

← 1 2 3 4 5 6 7 8 9 10 →